ADIL stock

Adial Pharmaceuticals Inc (ADIL) financials · $6.0M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Adial Pharmaceuticals Inc (ADIL) $6.0M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$7.80M-$8.28M
Net Income-$7.98M-$13.2M
EPS (Diluted)-$11.93-$2.72
Cached annual balance sheet
LineFY2025FY2024
Total Assets$6.67M$5.04M
Current Assets$6.18M$4.06M
Cash & Equivalents$5.88M$3.75M
Total Liabilities$1.40M$975.9K
Current Liabilities$1.40M$975.9K
Shareholders' Equity$5.28M$4.07M
Retained Earnings-$90.0M-$82.0M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$6.49M-$6.92M
Investing Cash Flow$150.0KN/A
Financing Cash Flow$8.47M$7.85M
These statements as JSON? API free 100/day

FAQ

What is ADIL P/E and revenue?

Adial Pharmaceuticals Inc (ADIL) $6.0M cap.

What is ADIL revenue?

ADIL income-statement cache has no revenue figure yet.

Is ADIL profitable?

Adial Pharmaceuticals Inc last cached net income is -$7.98M (FY2025).

What are ADIL total assets?

Adial Pharmaceuticals Inc last cached total assets are $6.67M (FY2025).

What is ADIL free cash flow?

No cached cash-flow row for ADIL yet.

Not investment advice. Cached statements, not a live tape.